Development and Application of an ELISA Assay Using Excretion/Secretion Proteins from Epimastigote Forms of T. cruzi (ESEA Antigens) for the Diagnosis of Chagas Disease

An indirect enzyme-linked immunoabsorbent assay (ELISA) for Trypanosoma cruzi was developed using epimastigote secretion/excretion proteins (ESEA antigens) obtained from axenic culture supernatants. A panel of 120 serum samples from subjects with confirmed Chagas disease (n = 50), healthy controls (n = 50), and patients with other parasitic diseases (n = 20) was used to evaluate the new ESEA-based ELISA (ELISAESEA). This new test had excellent sensitivity (98%) and acceptable specificity (88%). Cross-reactivity was observed largely in sera from subjects with Leishmania and Ascaris infections. Using Western blotting and epimastigotes from two distinct T. cruzi isolates, several polypeptide bands with molecular masses ranging from 50 to 220 kDa were detected in pooled chagasic sera. However, the band pattern for each isolate was different. These data suggest that an inexpensive and technically simple ELISA based on ESEA antigens is a promising new tool for the diagnosis of Chagas disease.

[1]  M. Gottschalk,et al.  85-kDa protein of Trypanosoma cruzi purified by affinity chromatography used in the multiple antigen binding assay (MABA) for the diagnosis of T. cruzi infection in a Venezuelan rural community , 2010, Parasitology Research.

[2]  K. Figarella,et al.  Serological diagnosis of Chagas disease: evaluation and characterisation of a low cost antigen with high sensitivity and specificity. , 2009, Memorias do Instituto Oswaldo Cruz.

[3]  John R. Crowther,et al.  The ELISA Guidebook , 2000, Methods in Molecular Biology™.

[4]  M. Busch,et al.  Evaluation of a new enzyme‐linked immunosorbent assay for detection of Chagas antibody in US blood donors , 2007, Transfusion.

[5]  M. Gottschalk,et al.  Field evaluation of four novel enzyme immunoassays for Chagas’ disease in Venezuela blood banks: comparison of assays using fixed‐epimastigotes, fixed‐trypomastigotes or trypomastigote excreted–secreted antigens from two Trypanosoma cruzi strains , 2006, Transfusion medicine.

[6]  M. Gottschalk,et al.  Purified Excreted-Secreted Antigens from Trypanosoma cruzi Trypomastigotes as Tools for Diagnosis of Chagas' Disease , 2006, Journal of Clinical Microbiology.

[7]  E. Silveira-Lacerda,et al.  Chagas’ disease: application of TESA‐blot in inconclusive sera from a Brazilian blood bank , 2004, Vox sanguinis.

[8]  M. Gottschalk,et al.  Development and Comparison of Enzyme Immunoassays for Diagnosis of Chagas' Disease Using Fixed Forms of Trypanosoma cruzi (Epimastigotes, Amastigotes, and Trypomastigotes) and Assessment of Antigen Stability for the Three Assays , 2004, Journal of Clinical Microbiology.

[9]  E. Chiari,et al.  Use of the Trypanosoma cruzi Recombinant Complement Regulatory Protein To Evaluate Therapeutic Efficacy following Treatment of Chronic Chagasic Patients , 2004, Journal of Clinical Microbiology.

[10]  D. Henríquez,et al.  Trypanosoma cruzi ubiquitin as an antigen in the differential diagnosis of Chagas disease and leishmaniasis. , 2003, FEMS immunology and medical microbiology.

[11]  C. Roodveldt,et al.  Purification of the 67-kDa lectin-like glycoprotein of Trypanosoma cruzi, LLGP-67, and its evaluation as a relevant antigen for the diagnosis of human infection. , 2003, FEMS microbiology letters.

[12]  M. Levin,et al.  An improved serodiagnostic test for Chagas' disease employing a mixture of Trypanosoma cruzi recombinant antigens , 2003, Transfusion.

[13]  E. Chiari,et al.  Trypanosoma cruzi Recombinant Complement Regulatory Protein: a Novel Antigen for Use in an Enzyme-Linked Immunosorbent Assay for Diagnosis of Chagas' Disease , 2002, Journal of Clinical Microbiology.

[14]  R. Corrêa-Oliveira,et al.  Use of the eie‐recombinant‐chagas‐biomanguinhos kit to monitor cure of human chagas’ disease , 2002, Journal of clinical laboratory analysis.

[15]  S. Reed,et al.  Enzyme-Linked Immunosorbent Assay for Serological Diagnosis of Chagas' Disease Employing a Trypanosoma cruziRecombinant Antigen That Consists of Four Different Peptides , 2001, Journal of Clinical Microbiology.

[16]  F. Abath,et al.  Excretory-Secretory Antigens of Trypanosoma cruzi Are Potentially Useful for Serodiagnosis of Chronic Chagas' Disease , 2001, Clinical Diagnostic Laboratory Immunology.

[17]  J. F. da Silveira,et al.  Chagas disease: recombinant Trypanosoma cruzi antigens for serological diagnosis. , 2001, Trends in parasitology.

[18]  S. Goldenberg,et al.  Serodiagnosis of chronic Chagas infection by using EIE-Recombinant-Chagas-Biomanguinhos kit. , 2001, Memorias do Instituto Oswaldo Cruz.

[19]  M. S. Nascimento,et al.  Enzyme-linked immunosorbent assay with Trypanosoma cruzi excreted-secreted antigens (TESA-ELISA) for serodiagnosis of acute and chronic Chagas' disease. , 2001, Diagnostic microbiology and infectious disease.

[20]  N. Kesper,et al.  Immunoblot Analysis of Trypomastigote Excreted–Secreted Antigens as a Tool for the Characterization of Trypanosoma cruzi Strains and Isolates , 2000, The Journal of parasitology.

[21]  C. Ramos,et al.  Diagnosis of Chagas'disease , 2000 .

[22]  S. Reed,et al.  Multiepitope synthetic peptide and recombinant protein for the detection of antibodies to Trypanosoma cruzi in patients with treated or untreated Chagas' disease. , 2000, The Journal of infectious diseases.

[23]  R. T. Pinho,et al.  Saliva ELISA: a method for the diagnosis of chronic Chagas disease in endemic areas. , 1999, Acta tropica.

[24]  C. Rossi,et al.  A rapid, quantitative enzyme-linked immunosorbent assay (ELISA) for the immunodiagnosis of Chagas' disease. , 1998, Immunological investigations.

[25]  I. C. Almeida,et al.  A highly sensitive and specific chemiluminescent enzyme‐linked immunosorbent assay for diagnosis of active Trypanosoma cruzi infection , 1997, Transfusion.

[26]  J. Coura,et al.  Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas' disease , 1996, Journal of clinical microbiology.

[27]  E. Umezawa,et al.  Alkaline soluble Trypanosoma cruzi epimastigote antigen (ASEA) applied to Dot-ELISA. , 1994, Revista do Instituto de Medicina Tropical de Sao Paulo.

[28]  J. Burns,et al.  Serodiagnosis of Chagas' disease by enzyme-linked immunosorbent assay using two synthetic peptides as antigens , 1994, Journal of clinical microbiology.

[29]  J. F. da Silveira,et al.  Identification and detection of Trypanosoma cruzi by using a DNA amplification fingerprint obtained from the ribosomal intergenic spacer , 1994, Journal of clinical microbiology.

[30]  R. Souto,et al.  Sensitive detection and strain classification of Trypanosoma cruzi by amplification of a ribosomal RNA sequence. , 1993, Molecular and biochemical parasitology.

[31]  M. Loyens,et al.  Evaluation of a competitive antibody enzyme immunoassay for specific diagnosis of Chagas' disease. , 1989, The Journal of parasitology.

[32]  M. Miles,et al.  Further evaluation of lectin affinity purified glycoprotein (GP90) in the enzyme linked immunosorbent assay (ELISA) for diagnosis of Trypanosoma cruzi infection. , 1985, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[33]  H. Berning.  [Diagnosis of Chagas disease]. , 2008, Deutsche medizinische Wochenschrift.

[34]  M. Miles,et al.  PURIFIED TRYPANOSOMA CRUZI SPECIFIC GLYCOPROTEIN FOR DISCRIMINATIVE SEROLOGICAL DIAGNOSIS OF SOUTH AMERICAN TRYPANOSOMIASIS (CHAGAS' DISEASE) , 1983, The Lancet.

[35]  J. Howie.  Significance of Escherichia coli in cheese. , 1981, Lancet.

[36]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[37]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.